Diana Zabini
- Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patientsBy Diana Zabini, Akos Heinemann, Vasile Foris, Chandran Nagaraj, Patrick Nierlich, Zoltán Bálint, Grazyna Kwapiszewska, Irene M. Lang, Walter Klepetko, Horst Olschewski and Andrea OlschewskiArticle | Published in 2014 in European Respiratory JournalDiana Zabini1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaAkos Heinemann2Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, AustriaVasile Foris1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaChandran Nagaraj1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaPatrick Nierlich3Dept of Surgery, Division of Thoracic Surgery, Medical University of Vienna, Vienna, AustriaZoltán Bálint1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaGrazyna Kwapiszewska1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria4Dept of Anaesthesia and Intensive Care Medicine, Experimental Anaesthesiology, Medical University of Graz, Graz, AustriaIrene M. Lang5Dept of Internal Medicine II, Cardiology, Medical University of Vienna, Vienna, AustriaWalter Klepetko3Dept of Surgery, Division of Thoracic Surgery, Medical University of Vienna, Vienna, AustriaHorst Olschewski6Dept of Internal Medicine, Division of Pulmonology, Medical University of Graz, Graz, AustriaAndrea Olschewski1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria4Dept of Anaesthesia and Intensive Care Medicine, Experimental Anaesthesiology, Medical University of Graz, Graz, Austria
- Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patientsBy Diana Zabini, Akos Heinemann, Vasile Foris, Chandran Nagaraj, Patrick Nierlich, Zoltán Bálint, Grazyna Kwapiszewska, Irene M. Lang, Walter Klepetko, Horst Olschewski and Andrea OlschewskiDiana Zabini1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaAkos Heinemann2Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, AustriaVasile Foris1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaChandran Nagaraj1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaPatrick Nierlich3Dept of Surgery, Division of Thoracic Surgery, Medical University of Vienna, Vienna, AustriaZoltán Bálint1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, AustriaGrazyna Kwapiszewska1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria4Dept of Anaesthesia and Intensive Care Medicine, Experimental Anaesthesiology, Medical University of Graz, Graz, AustriaIrene M. Lang5Dept of Internal Medicine II, Cardiology, Medical University of Vienna, Vienna, AustriaWalter Klepetko3Dept of Surgery, Division of Thoracic Surgery, Medical University of Vienna, Vienna, AustriaHorst Olschewski6Dept of Internal Medicine, Division of Pulmonology, Medical University of Graz, Graz, AustriaAndrea Olschewski1Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria4Dept of Anaesthesia and Intensive Care Medicine, Experimental Anaesthesiology, Medical University of Graz, Graz, Austria
- SMAD3 regulation contributes to lung vascular remodeling in pulmonary arterial hypertensionBy Diana Zabini, Andras Kapus and Wolfgang KueblerDiana Zabini1Keenan Research Centre of Biomedical Science, St. Michael's Hospital, Toronto, ON CanadaAndras Kapus1Keenan Research Centre of Biomedical Science, St. Michael's Hospital, Toronto, ON Canada2Dept. of Surgery, University of Toronto, Toronto, ON CanadaWolfgang Kuebler1Keenan Research Centre of Biomedical Science, St. Michael's Hospital, Toronto, ON Canada2Dept. of Surgery, University of Toronto, Toronto, ON Canada3Dept. of Physiology, Charité, Universitätsmedizin Berlin, Berlin, Germany
- Cystic fibrosis transmembrane conductance regulator and sphingolipids regulate hypoxic pulmonary vasoconstrictionBy Christoph Tabeling, Hanpo Yu, Liming Wang, Hannes Ranke, Neil M. Goldenberg, Diana Zabini, Elena Noe, Adrienn Krauszman, Birgitt Gutbier, Jun Yin, Michael Schaefer, Christoph Arenz, Andreas C. Hocke, Norbert Suttorp, Richard L. Proia, Martin Witzenrath and Wolfgang M. KueblerChristoph Tabeling1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyHanpo Yu2The Keenan Research Centre for Biomedical Science, St. Michael's, Toronto, Canada3Department of Physiology, Charité - Universitätsmedizin Berlin, Berlin, GermanyLiming Wang2The Keenan Research Centre for Biomedical Science, St. Michael's, Toronto, Canada3Department of Physiology, Charité - Universitätsmedizin Berlin, Berlin, GermanyHannes Ranke2The Keenan Research Centre for Biomedical Science, St. Michael's, Toronto, Canada3Department of Physiology, Charité - Universitätsmedizin Berlin, Berlin, GermanyNeil M. Goldenberg2The Keenan Research Centre for Biomedical Science, St. Michael's, Toronto, Canada3Department of Physiology, Charité - Universitätsmedizin Berlin, Berlin, GermanyDiana Zabini2The Keenan Research Centre for Biomedical Science, St. Michael's, Toronto, Canada3Department of Physiology, Charité - Universitätsmedizin Berlin, Berlin, GermanyElena Noe1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyAdrienn Krauszman2The Keenan Research Centre for Biomedical Science, St. Michael's, Toronto, Canada3Department of Physiology, Charité - Universitätsmedizin Berlin, Berlin, GermanyBirgitt Gutbier1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyJun Yin2The Keenan Research Centre for Biomedical Science, St. Michael's, Toronto, Canada3Department of Physiology, Charité - Universitätsmedizin Berlin, Berlin, GermanyMichael Schaefer4Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, GermanyChristoph Arenz5Institute for Chemistry, Humboldt University, Berlin, GermanyAndreas C. Hocke1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyNorbert Suttorp1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyRichard L. Proia6Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, United StatesMartin Witzenrath1Department of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, GermanyWolfgang M. Kuebler2The Keenan Research Centre for Biomedical Science, St. Michael's, Toronto, Canada3Department of Physiology, Charité - Universitätsmedizin Berlin, Berlin, Germany
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
